Announcements
Projects
Orgs
Project Post
Articles 130
Votes 0
Endpoints News

Authors 22

Max Gelman
Tyler Patchen
Lei Lei Wu
Amber Tong
John Carroll
Zachary Brennan
Kyle LaHucik
Nicole DeFeudis
Paul Schloesser
Katherine Lewin
Beth Snyder Bulik
Katherine
Andrew Dunn
Drew Armstrong
Ryan Cross
Jared Whitlock
Reynald Castañeda
Jaimy Lee
Ayisha Sharma
Anna Brown
Lia DeGroot
ENDPOINTS
AbbVie beats second-quarter earnings projections as Humira competitors see slow uptake - Endpoints News
almost2y
'An unholy union': Stanford scientists create a drug that flips cancer driver into killer - Endpoints News
almost2y
ViiV's long-acting HIV injectable Cabenuva preferred over Biktarvy by 90% of patients in PhIII trial - Endpoints News
almost2y
FDA approves Daiichi Sankyo's new first-line AML drug quizartinib with boxed warning for heart disorders - Endpoints News
almost2y
No more FDA adcomm votes? Reforms brew as new research highlights decline in meetings - Endpoints News
~2y
In a first, FDA signs off on CellTrans' type 1 diabetes cell therapy days after industry's eyes fixated on Vertex data - Endpoints News
~2y
FDA rejects higher dose of Regeneron blockbuster due to contractor issues - Endpoints News
~2y
FDA's Peter Marks overrode reviewers' call to reject Sarepta's new Duchenne gene therapy - Endpoints News
~2y
CAR-T cell therapy for myasthenia gravis shows promise in small study by Cartesian Therapeutics - Endpoints News
~2y
Prime Medicine considers focus on autoimmune diseases for CAR-T, CEO says - Endpoints News
~2y
Xalud Therapeutics prioritizes gene therapies, with ALS now the focus and osteoarthritis on partner path - Endpoints News
~2y
Exclusive: Illumina CEO Francis deSouza resigns, following challenge by activist investor - Endpoints News
~2y
FDA sets December approval decision for first CRISPR therapy, with 94% of patients free of sickle cell crises - Endpoints News
~2y
After gene therapy deaths, Astellas to revisit fatal neuromuscular condition in partnership with biotech startup - Endpoints News
~2y
Grail's blood test charts path for diagnosing patients suspected of having cancer in large study: #ASCO23 - Endpoints News
~2y
CMS makes it official: Coverage for new Alzheimer's drugs once full approvals arrive - Endpoints News
~2y
With Moderna windfall, Harvard professor and integrins legend Tim Springer donates $210M to his Institute for Protein Innovation - Endpoints News
~2y
Pfizer’s oral GLP-1 shows weight loss potential in new PhII data - Endpoints News
~2y
CBER chief Peter Marks to consider 'alternatives' to clinical holds as they 'put shudders down investors' spines' - Endpoints News
~2y
Breaking: SCOTUS rules unanimously in favor of Sanofi and Regeneron in PCSK9 patent spat with Amgen - Endpoints News
~2y
Amgen's CEO says he's 'confident' their $28B deal with Horizon can close despite FTC lawsuit - Endpoints News
~2y
Peter Hecht has a new syndicate, $81M in backing and a fresh shot at glory as his last start-up sputters out - Endpoints News
~2y
SCOTUS declines to take up 'skinny' label generic drug case, raising questions about future carve outs - Endpoints News
~2y
CVS will shut down clinical trials unit that it launched during Covid - Endpoints News
~2y
FDA adcomm backs accelerated approval of Sarepta's Duchenne gene therapy in close vote - Endpoints News
~2y